Business Description
Aprogen Biologics Inc
ISIN : KR7003060001
Description
Financial Strength
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.14 | |||||
Equity-to-Asset | 0.64 | |||||
Debt-to-Equity | 0.42 | |||||
Debt-to-EBITDA | -1.3 | |||||
Piotroski F-Score | 1/9 | |||||
Altman Z-Score | -0.53 | |||||
Beneish M-Score | -6.22 | |||||
WACC vs ROIC |
Growth Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -5.9 | |||||
3-Year Book Growth Rate | -23.8 |
Momentum Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 53.32 | |||||
9-Day RSI | 46.7 | |||||
14-Day RSI | 45.07 | |||||
6-1 Month Momentum % | -21.12 | |||||
12-1 Month Momentum % | -65.77 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.71 | |||||
Quick Ratio | 0.36 | |||||
Cash Ratio | 0.15 | |||||
Days Inventory | 245.53 | |||||
Days Sales Outstanding | 82.63 | |||||
Days Payable | 13.88 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -18.2 | |||||
Shareholder Yield % | -37.99 |
Profitability Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | -8.72 | |||||
Operating Margin % | -87.92 | |||||
Net Margin % | -178.1 | |||||
FCF Margin % | -61.88 | |||||
ROE % | -31.56 | |||||
ROA % | -20.27 | |||||
ROIC % | -9.99 | |||||
3-Year ROIIC % | -23.19 | |||||
ROC (Joel Greenblatt) % | -40.44 | |||||
ROCE % | -28.8 | |||||
Years of Profitability over Past 10-Year | 4 |
GF Value Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 1.05 | |||||
PB Ratio | 0.32 | |||||
Price-to-Tangible-Book | 0.33 | |||||
EV-to-EBIT | -2.24 | |||||
EV-to-EBITDA | -2.58 | |||||
EV-to-Revenue | 4.44 | |||||
EV-to-FCF | -7.18 | |||||
Price-to-Projected-FCF | 0.3 | |||||
Price-to-Median-PS-Value | 0.17 | |||||
Earnings Yield (Greenblatt) % | -44.64 | |||||
FCF Yield % | -24.43 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Aprogen Biologics Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil â‚©) | 73,635.001 | ||
EPS (TTM) (â‚©) | -1623.461 | ||
Beta | 0.65 | ||
Volatility % | 48.52 | ||
14-Day RSI | 45.07 | ||
14-Day ATR (â‚©) | 60.223022 | ||
20-Day SMA (â‚©) | 1003.3 | ||
12-1 Month Momentum % | -65.77 | ||
52-Week Range (â‚©) | 907 - 3419.730556 | ||
Shares Outstanding (Mil) | 197.57 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 1 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Aprogen Biologics Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Aprogen Biologics Inc Stock Events
Event | Date | Price(â‚©) | ||
---|---|---|---|---|
No Event Data |
Aprogen Biologics Inc Frequently Asked Questions
What is Aprogen Biologics Inc(XKRX:003060)'s stock price today?
When is next earnings date of Aprogen Biologics Inc(XKRX:003060)?
Does Aprogen Biologics Inc(XKRX:003060) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |